A Jakubczyk1, M A Ilgen2, M Kopera3, A Krasowska4, A Klimkiewicz5, A Bohnert6, F C Blow7, K J Brower8, M Wojnar9. 1. Department of Psychiatry, Medical University of Warsaw, 27 Nowowiejska St., 00-665 Warsaw, Poland. Electronic address: ajakubczyk@wum.edu.pl. 2. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, USA. Electronic address: marki@med.umich.edu. 3. Department of Psychiatry, Medical University of Warsaw, 27 Nowowiejska St., 00-665 Warsaw, Poland. Electronic address: maciej.kopera@wum.edu.pl. 4. Department of Psychiatry, Medical University of Warsaw, 27 Nowowiejska St., 00-665 Warsaw, Poland. Electronic address: aleksandra.krasowska@gmail.com. 5. Department of Psychiatry, Medical University of Warsaw, 27 Nowowiejska St., 00-665 Warsaw, Poland. Electronic address: anna.klimkiewicz@mlodylekarz.pl. 6. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, USA. Electronic address: amybohne@med.umich.edu. 7. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, USA. Electronic address: fredblow@med.umich.edu. 8. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. Electronic address: kbrower@med.umich.edu. 9. Department of Psychiatry, Medical University of Warsaw, 27 Nowowiejska St., 00-665 Warsaw, Poland; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. Electronic address: marcin.wojnar@wum.edu.pl.
Abstract
OBJECTIVE: Physical pain is considered a potential predictor of relapse in alcohol-dependent individuals after treatment. The aim of this study was to evaluate whether reductions in pain level during the follow-up period after treatment were associated with lower relapse risk. METHOD: A sample of 366 participants was recruited from alcohol treatment centers in Warsaw, Poland. At baseline, information was obtained about pain level, demographics, childhood abuse, impulsivity, depressive symptoms, severity of alcohol and sleep problems. After finishing the alcohol treatment program, patients were followed for 12 months and alcohol drinking (relapse) as well as pain severity were evaluated. RESULTS: In the followed-up group, 29.5% of patients confirmed that they drank any alcohol during past 4 weeks. Comparing follow-up to baseline pain, 48.6% of subjects reported an increased severity of pain, 28.8% reported the same level of pain, 22.6% reported decreased level of pain. There was a significant association between the decrease in level of pain and the lower risk of relapse. Other factors associated with relapse during 4 weeks prior to the follow-up were baseline severity of depressive symptoms, low baseline social support and number of drinking days during 4 weeks prior to entering treatment. In multivariate analysis, a decrease in pain level was associated with a lower likelihood of relapse (OR=0.159; 95%CI:0.04-0.62; p=0.008) even when controlled for other factors associated with relapse. CONCLUSIONS: Decreases in pain level following treatment for alcohol dependence are associated with, and may contribute to, a lower risk of alcohol relapse.
OBJECTIVE: Physical pain is considered a potential predictor of relapse in alcohol-dependent individuals after treatment. The aim of this study was to evaluate whether reductions in pain level during the follow-up period after treatment were associated with lower relapse risk. METHOD: A sample of 366 participants was recruited from alcohol treatment centers in Warsaw, Poland. At baseline, information was obtained about pain level, demographics, childhood abuse, impulsivity, depressive symptoms, severity of alcohol and sleep problems. After finishing the alcohol treatment program, patients were followed for 12 months and alcohol drinking (relapse) as well as pain severity were evaluated. RESULTS: In the followed-up group, 29.5% of patients confirmed that they drank any alcohol during past 4 weeks. Comparing follow-up to baseline pain, 48.6% of subjects reported an increased severity of pain, 28.8% reported the same level of pain, 22.6% reported decreased level of pain. There was a significant association between the decrease in level of pain and the lower risk of relapse. Other factors associated with relapse during 4 weeks prior to the follow-up were baseline severity of depressive symptoms, low baseline social support and number of drinking days during 4 weeks prior to entering treatment. In multivariate analysis, a decrease in pain level was associated with a lower likelihood of relapse (OR=0.159; 95%CI:0.04-0.62; p=0.008) even when controlled for other factors associated with relapse. CONCLUSIONS: Decreases in pain level following treatment for alcohol dependence are associated with, and may contribute to, a lower risk of alcohol relapse.
Authors: Valerie A Cardenas; Timothy C Durazzo; Stefan Gazdzinski; Anderson Mon; Colin Studholme; Dieter J Meyerhoff Journal: Biol Psychiatry Date: 2011-05-20 Impact factor: 13.382
Authors: Lynn Boschloo; Nicole Vogelzangs; Wim van den Brink; Johannes H Smit; Aartjan T F Beekman; Brenda W J H Penninx Journal: Addiction Date: 2012-04-17 Impact factor: 6.526
Authors: Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Richard S Schottenfeld; Robert D Kerns; Brent A Moore; Lindsay Oberleitner; Michelle T Joy; Nina Keneally; Christopher Liong; Kathleen M Carroll Journal: J Addict Med Date: 2014 Sep-Oct Impact factor: 3.702
Authors: Andrzej Jakubczyk; Mark A Ilgen; Amy S B Bohnert; Maciej Kopera; Aleksandra Krasowska; Anna Klimkiewicz; Frederic C Blow; Kirk J Brower; Marcin Wojnar Journal: J Stud Alcohol Drugs Date: 2015-07 Impact factor: 2.582
Authors: Cynthia I Campbell; Andrea H Kline-Simon; Michael Von Korff; Kathleen W Saunders; Constance Weisner Journal: Subst Use Misuse Date: 2017-03-27 Impact factor: 2.164
Authors: Anne C Fernandez; Christopher Bush; Erin E Bonar; Frederic C Blow; Maureen A Walton; Amy S B Bohnert Journal: J Addict Med Date: 2019 Jan/Feb Impact factor: 3.702
Authors: Jessica A Cucinello-Ragland; Roshaun Mitchell-Cleveland; W Bradley Trimble; Amy P Urbina; Alice Y Yeh; Kimberly N Edwards; Patricia E Molina; Liz Simon Peter; Scott Edwards Journal: Neurosci Lett Date: 2021-07-17 Impact factor: 3.197